MedTrace Logo

Study to Treat Uveitis Associated Macular Edema

NCT00114062 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-11-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether denufosol tetrasodium (INS37217) Intravitreal Injection is well tolerated and has the potential to treat uveitis associated macular edema.

Conditions

  • Cystoid Macular Edema
  • Uveitis

Interventions

DRUG

denufosol tetrasodium (INS37217) Intravitreal Injection

Sponsors & Collaborators

Principal Investigators

  • Amy Schaberg, BSN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2006-12-31
Completion
2006-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00114062 on ClinicalTrials.gov